164 related articles for article (PubMed ID: 35892885)
41. Accelerated dose escalation with proton beam therapy for non-small cell lung cancer.
Gomez DR; Chang JY
J Thorac Dis; 2014 Apr; 6(4):348-55. PubMed ID: 24688779
[TBL] [Abstract][Full Text] [Related]
42. Clinical Efficacy of Hypofractionated Proton Beam Therapy for Intrahepatic Cholangiocarcinoma.
Kim TH; Woo SM; Lee WJ; Chun JW; Cho YR; Kim BH; Koh YH; Kim SS; Oh ES; Lee DY; Lee SU; Suh YG; Moon SH; Park JW
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428654
[TBL] [Abstract][Full Text] [Related]
43. Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.
Wang J; Zhou Z; Liang J; Feng Q; Xiao Z; Hui Z; Wang X; Lv J; Chen D; Zhang H; Ji Z; Cao J; Liu L; Jiang W; Men Y; Xu C; Dai J; Yin W; Wang L
Oncologist; 2016 Dec; 21(12):1530-1537. PubMed ID: 27628491
[TBL] [Abstract][Full Text] [Related]
44. A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer.
Wang X; Zamdborg L; Ye H; Grills IS; Yan D
BMC Cancer; 2018 Oct; 18(1):962. PubMed ID: 30305131
[TBL] [Abstract][Full Text] [Related]
45. Adjuvant Proton Beam Therapy in the Management of Thymoma: A Dosimetric Comparison and Acute Toxicities.
Parikh RR; Rhome R; Hug E; Tsai H; Cahlon O; Chon B; Goenka A
Clin Lung Cancer; 2016 Sep; 17(5):362-366. PubMed ID: 27372386
[TBL] [Abstract][Full Text] [Related]
46. Toxicity of Proton Therapy versus Photon Therapy on Salvage Re-Irradiation for Non-Small Cell Lung Cancer.
Yang K; Suh YG; Shin H; Pyo H; Moon SH; Ahn YC; Oh D; Chung E; Jo K; Noh JM
Life (Basel); 2022 Feb; 12(2):. PubMed ID: 35207579
[TBL] [Abstract][Full Text] [Related]
47. Clinical outcomes and toxicities of proton radiotherapy for gastrointestinal neoplasms: a systematic review.
Verma V; Lin SH; Simone CB; Mehta MP
J Gastrointest Oncol; 2016 Aug; 7(4):644-64. PubMed ID: 27563457
[TBL] [Abstract][Full Text] [Related]
48. Proton beam therapy in rectal cancer: A systematic review and meta-analysis.
Fok M; Toh S; Easow J; Fowler H; Clifford R; Parsons J; Vimalachandran D
Surg Oncol; 2021 Sep; 38():101638. PubMed ID: 34340196
[TBL] [Abstract][Full Text] [Related]
49. Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC).
von Reibnitz D; Shaikh F; Wu AJ; Treharne GC; Dick-Godfrey R; Foster A; Woo KM; Shi W; Zhang Z; Din SU; Gelblum DY; Yorke ED; Rosenzweig KE; Rimner A
Acta Oncol; 2018 Nov; 57(11):1567-1573. PubMed ID: 29873277
[TBL] [Abstract][Full Text] [Related]
50. Prognostic factors in medically inoperable early stage lung cancer patients treated with stereotactic ablative radiation therapy (SABR): Turkish Radiation Oncology Society Multicentric Study.
Sahin B; Atalar B; Kaytan Saglam E; Akgun Z; Abacioglu U; Arifoglu A; Ozyar E; Yaprak G; Ozseker Isik N; Guney Y; Caglar HB; Karaman S; Igdem S; Selek U; Berber T; Oner Dincbas F; Sengoz M; Yucel S; Demiral AN; Akyurek S
Clin Respir J; 2020 Nov; 14(11):1050-1059. PubMed ID: 32749053
[TBL] [Abstract][Full Text] [Related]
51. Comparative toxicity outcomes of proton-beam therapy versus intensity-modulated radiotherapy for prostate cancer in the postoperative setting.
Santos PMG; Barsky AR; Hwang WT; Deville C; Wang X; Both S; Bekelman JE; Christodouleas JP; Vapiwala N
Cancer; 2019 Dec; 125(23):4278-4293. PubMed ID: 31503338
[TBL] [Abstract][Full Text] [Related]
52. Accelerated Hypofractionated Radiotherapy Versus Stereotactic Body Radiotherapy for the Treatment of Stage I Nonsmall Cell Lung Cancer-A Single Institution Experience With Long-Term Follow-Up.
Karasawa K; Hayakawa S; Machitori Y; Shibata Y; Ogawa H; Ito K; Shimizuguchi T; Kawamoto T; Nihei K
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806318. PubMed ID: 30317929
[TBL] [Abstract][Full Text] [Related]
53. A Propensity-Matched Analysis of Survival of Clinically Diagnosed Early-Stage Lung Cancer and Biopsy-Proven Early-Stage Non-Small Cell Lung Cancer Following Stereotactic Ablative Radiotherapy.
Zhang R; Guo Y; Yan Y; Liu Y; Zhu Y; Kang J; Li F; Sun X; Xing L; Xu Y
Front Oncol; 2021; 11():720847. PubMed ID: 34504798
[TBL] [Abstract][Full Text] [Related]
54. Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non-Small Cell Lung Cancer.
Speirs CK; DeWees TA; Rehman S; Molotievschi A; Velez MA; Mullen D; Fergus S; Trovo M; Bradley JD; Robinson CG
J Thorac Oncol; 2017 Feb; 12(2):293-301. PubMed ID: 27743888
[TBL] [Abstract][Full Text] [Related]
55. Particle Beam Radiation Therapy for Adenoid Cystic Carcinoma of the Nasal Cavity and Paranasal Sinuses.
Hu W; Hu J; Huang Q; Gao J; Yang J; Qiu X; Kong L; Lu JJ
Front Oncol; 2020; 10():572493. PubMed ID: 33102230
[No Abstract] [Full Text] [Related]
56. Stereotactic body radiotherapy for adrenal oligometastasis in lung cancer patients.
Arcidiacono F; Aristei C; Marchionni A; Italiani M; Fulcheri CPL; Saldi S; Casale M; Ingrosso G; Anselmo P; Maranzano E
Br J Radiol; 2020 Nov; 93(1115):20200645. PubMed ID: 32822540
[TBL] [Abstract][Full Text] [Related]
57. A Comparative Analysis of Photon versus Proton Beam Therapy in Neoadjuvant Concurrent Chemoradiotherapy for Intrathoracic Squamous Cell Carcinoma of the Esophagus at a Single Institute.
Choi JH; Lee JM; Kim MS; Lee Y; Suh YG; Lee SU; Lee DY; Oh ES; Kim TH; Moon SH
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454939
[TBL] [Abstract][Full Text] [Related]
58. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
Seco J; Gu G; Marcelos T; Kooy H; Willers H
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
[TBL] [Abstract][Full Text] [Related]
59. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced non-small cell lung cancer.
Wu CT; Motegi A; Motegi K; Hotta K; Kohno R; Tachibana H; Kumagai M; Nakamura N; Hojo H; Niho S; Goto K; Akimoto T
Jpn J Clin Oncol; 2016 Nov; 46(11):1008-1014. PubMed ID: 27511988
[TBL] [Abstract][Full Text] [Related]
60. Cardiac Dose and Survival After Stereotactic Body Radiotherapy for Early-stage Non-Small-cell Lung Cancer.
Tembhekar AR; Wright CL; Daly ME
Clin Lung Cancer; 2017 May; 18(3):293-298. PubMed ID: 28089158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
